Godx-sbir phase i award
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93022C00018
- Awardee
-
Godx Inc. UEI FZPKPXA6S8L8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,596,552
Award facts
- Contract value 100% obligated
- $1,596,552.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53719, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | -$200,000 | |
| Exercise an Option | $1,496,744 | |
| Other Administrative Action | $0 | |
| Original award | $299,808 |
About this award
This is a Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Godx Inc., a minority-owned small business. The $1,596,552.00 contract is for the development of a rapid, low-cost, point-of-care diagnostic test to detect enteric pathogens and antibiotic resistance. The goal is to create a diagnostic tool that can identify cholera, salmonella, shigella, and other pathogens directly from stool samples to enable prompt treatment and reduce antibiotic over-prescription. This contract is not associated with a set-aside program and has a performance period ending on December 31, 2025. Godx Inc. has previously received multiple federal grants from NIAID for the development of rapid point-of-care diagnostics for other infectious diseases, such as sexually transmitted infections and antibiotic-resistant gonorrhea.
Quick answers
Who was awarded contract 75N93022C00018?
75N93022C00018 was awarded to Godx Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2022.
How much is contract 75N93022C00018 worth?
The government has obligated $1,596,552 on 75N93022C00018.
Was contract 75N93022C00018 competed?
The extent of competition for 75N93022C00018 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award